Osteosarcoma Therapy: Inhibition of CaMKIIα Activity Enhances Antitumor Effect of Fullerene C60 Nanocrystals by Suppression of Autophagic Degradation (adv. Sci. 8/2019)

Jing Xu,Hongsheng Wang,Yi Hu,Yu Shrike Zhang,Longping Wen,Fei Yin,Zhuoying Wang,Yingchao Zhang,Suoyuan Li,Yanyan Miao,Binhui Lin,Dongqing Zuo,Gangyang Wang,Min Mao,Tao Zhang,Jianxun Ding,Yingqi Hua,Zhengdong Cai
DOI: https://doi.org/10.1002/advs.201970051
IF: 15.1
2019-01-01
Advanced Science
Abstract:In article number 1801233, Jianxun Ding, Yingqi Hua, Zhengdong Cai, and co-workers report a combination strategy for improving the efficacy of fullerene C60 nanocrystals in anti-osteosarcoma therapy. Inhibition of CaMKIIα activity by KN-93 promotes excessive autophagosome accumulation and autophagic degradation blockage through lysosomal dysfunction induction and further upregulates the anti-osteosarcoma effect of fullerene C60 nanocrystals.
What problem does this paper attempt to address?